LuciAlpe 150 mg is an anticancer medicine used in
combination therapy for hormone receptor positive advanced breast cancer with
specific genetic mutations. It helps slow disease progression and improve
treatment outcomes. This medicine is widely prescribed across the United
Kingdom, United States, Australia, Singapore and Philippines as part of
targeted cancer therapy. LuciAlpe plays a vital role in modern oncology by
offering a personalized treatment approach when used under specialist
supervision.
Active Ingredient
Alpelisib is a phosphatidylinositol 3 kinase inhibitor that targets the PI3K
pathway involved in cancer cell growth. By blocking this pathway it helps
reduce tumor proliferation and enhances response to hormone therapy.
Uses of LuciAlpe 150 mg
• Treatment of advanced breast cancer
• Management of PIK3CA mutated cancers
• Relief from cancer progression symptoms
• Support for targeted therapy
How LuciAlpe 150 mg Works
Alpelisib inhibits the PI3K signaling pathway which is often overactive in
cancer cells. This reduces cell growth and survival leading to slowed tumor
progression and improved treatment response.
How to Use LuciAlpe 150 mg
- Take
once daily with food
- Swallow
tablets whole
- Follow
oncologist instructions carefully
Possible Side Effects
• High blood sugar
• Rash
• Diarrhea
• Fatigue
Precautions
• Monitor blood glucose regularly
• Inform doctor about skin conditions
• Avoid during pregnancy
Safety Information
Take only under specialist supervision. Regular monitoring is essential to
ensure safe and effective treatment outcomes.
Storage
• Store below 30°C
• Keep in original packaging
• Keep away from children